{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:28:41Z","timestamp":1791437321777,"version":"4.3.3"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lymphatic Research and Biology"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cellulitis is a common and often recurrent infection that causes substantial financial burden and morbidity. Compression therapy reduces the risk of recurrent cellulitis episodes for adults with chronic edema; however, little is known about the cost-effectiveness of the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results:<\/jats:title>\n                    <jats:p>A cost analysis was undertaken during a randomized controlled trial (RCT) involving 84 participants with lower limb chronic edema and a history of recurrent cellulitis. The intervention group received compression therapy and education, while the control group received education only. A clinical audit and survey were used to measure health service and patient resource use for (1) the most recent episode of cellulitis, and (2) compression therapy over 18 months. Australian reference costs were used to calculate cellulitis and compression therapy costs, and the mean expenditure in both the RCT groups. Of the 84 RCT participants, 43 were surveyed and audited on the cost of cellulitis, and 40 on the cost of compression therapy. The mean cost of a hospitalized and nonhospitalized episode of cellulitis was $9071 and $506 from a health service perspective, and $4496 and $1320 from a patient perspective. The mean cost of compression therapy per participant over 18 months was $1905 and $421 from health service and patient perspectives, respectively. During the RCT, the mean annual cost per participant was $4972 in the experimental group and $26,382 in the control group, giving a cost-saving of $21,483 (95% confidence interval, 3136\u201348,176) per participant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For patients with lower limb chronic edema and recurrent cellulitis, compression therapy is both efficacious and cost-saving. Trial Registration: ACTRN12617000412336.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/lrb.2022.0029","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:50:28Z","timestamp":1661248228000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Compression Therapy Is Cost-Saving in the Prevention of Lower Limb Recurrent Cellulitis in Patients with Chronic Edema"],"prefix":"10.1177","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-4372","authenticated-orcid":false,"given":"Elizabeth","family":"Webb","sequence":"first","affiliation":[{"name":"Physiotherapy Department, Calvary Public Hospital Bruce, Canberra, Australia."},{"name":"Discipline of Physiotherapy, Faculty of Health, University of Canberra, Canberra, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernie","family":"Bissett","sequence":"additional","affiliation":[{"name":"Discipline of Physiotherapy, Faculty of Health, University of Canberra, Canberra, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Neeman","sequence":"additional","affiliation":[{"name":"Biological Data Science Institute, the Australian National University Joint Colleges of Science, Health, and Medicine, Australian National University, Canberra, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bowden","sequence":"additional","affiliation":[{"name":"Medical School, Australian National University, Canberra, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Preston","sequence":"additional","affiliation":[{"name":"Discipline of Physiotherapy, Faculty of Health, University of Canberra, Canberra, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mumford","sequence":"additional","affiliation":[{"name":"Australian Institute of Health Innovation, Macquarie University, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07419.x"},{"key":"e_1_3_7_3_2","unstructured":"Australian Institute of Health and Welfare 2018. Emergency department care 2017\u20132018: Australian hospital statistics. https:\/\/www.aihw.gov.au\/getmedia\/9ca4c770-3c3b-42fe-b071-3d758711c23a\/aihw-hse-216.pdf.aspx?inline=true (accessed September10 2021)."},{"key":"e_1_3_7_4_2","unstructured":"Independent Hospital Pricing Authority . National Hospital cost data collection report public sector Round 22 (financial year 2017\u20132018). February 2021. https:\/\/www.ihpa.gov.au\/publications\/national-hospital-cost-data-collection-report-public-sector-round-22-financial-year (accessed June11 2021)."},{"key":"e_1_3_7_5_2","unstructured":"Independent Hospital Pricing Authority. National Hospital cost data collection: What is the cost of Australia's emergency care patients? 2020. https:\/\/www.ihpa.gov.au\/sites\/default\/files\/publications\/round_22_nhcdc_infographics_emergency.pdf (accessed June11 2021)."},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2017.1384690"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01657.x"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-270"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02906.x"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-014-0422-0"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19803"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206300"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10586.x"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917197"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.02.017"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029225"},{"key":"e_1_3_7_17_2","unstructured":"Australian Government Department of Health. Schedule of pharmaceutical benefits. January 2018. https:\/\/www.pbs.gov.au\/info\/publication\/schedule\/archive (accessed July13 2021)."},{"key":"e_1_3_7_18_2","unstructured":"Australian Government Department of Health. Pharmaceutical benefits: Fees patient contributions and safety net thresholds. https:\/\/www.pbs.gov.au\/info\/healthpro\/explanatory-notes\/front\/fee (accessed July13 2021)."},{"key":"e_1_3_7_19_2","unstructured":"Australian Government Department of Social Services. Age pension. https:\/\/www.dss.gov.au\/seniors\/benefits-payments\/age-pension (accessed July16 2021)."},{"key":"e_1_3_7_20_2","unstructured":"Independent Hospital Pricing Authority. Australian Refined Diagnosis Related Groups version 10.0 final report. https:\/\/www.ihpa.gov.au\/what-we-do\/admitted-acute-care\/ar-drg-version-10 (accessed July16 2021)."},{"key":"e_1_3_7_21_2","unstructured":"Australian Government Department of Health. Medicare benefits schedule book: Operating from 1 January 2018. 2017. www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/90CB91EE0B6FB8A9CA2586140082584E\/$File\/201801-MBS.pdf (accessed July13 2021)."},{"key":"e_1_3_7_22_2","unstructured":"Australian Government Department of Health. Annual Medicare statistics. 2020. https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/Medicare%20Statistics-1 (accessed July13 2021)."},{"key":"e_1_3_7_23_2","unstructured":"Australian Bureau of Statistics . Average weekly earnings Australia May 2018. August 2018. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/6302.0Main+Features1May%202018 (accessed July16 2021)."},{"key":"e_1_3_7_24_2","unstructured":"National Disability Insurance Agency . NDIS price guide: Australian Capital Territory Northern Territory South Australia Western Australia. 2017. file:\/\/\/C:\/Users\/lizzi\/Downloads\/PB%20Price%20Guide%20201718%20ACT%20NT%20SA%20WA%20PDF_1.pdf (accessed July23 2021)."},{"key":"e_1_3_7_25_2","unstructured":"Australian Government Australia Taxation Office. Car expenses. May 2021. https:\/\/www.ato.gov.au\/Individuals\/Income-and-deductions\/Deductions-you-can-claim\/Transport-and-travel-expenses\/Car-expenses (accessed July16 2021)."},{"key":"e_1_3_7_26_2","unstructured":"Australian Tax Office. Rates for financial year ending 30 June 2018. https:\/\/www.ato.gov.au\/Tax-professionals\/TP\/Financial-year-ending-30-June-2018 (accessed February1 2022)."},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0844562118786647"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv413"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.023"},{"key":"e_1_3_7_30_2","unstructured":"Lymphoedema Framework. Best Practice for the Management of Lymphoedema. International consensus. London: MEP Ltd.; 2006."},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.03999-8"},{"key":"e_1_3_7_32_2","unstructured":"SAGE GROUP. Chronic venous disease (CVD): Epidemiology costs and consequences. http:\/\/thesagegroup.us\/pages\/reports\/CVD-report.php (accessed November23 2021)."},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2018.0085"},{"key":"e_1_3_7_34_2","first-page":"CD000265","article-title":"Compression for venous leg ulcers","volume":"11","author":"O'Meara S","year":"2012","unstructured":"O'Meara S, , Cullum N, , Nelson EA, et al. Compression for venous leg ulcers. Cochrane Database Syst Rev, 2012; 11:CD000265.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_35_2","first-page":"CD002303","article-title":"Compression for preventing recurrence of venous ulcers","volume":"9","author":"Nelson EA","year":"2014","unstructured":"Nelson EA, , Bell-Syer SE. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev, 2014; 9:CD002303.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_36_2","first-page":"19","article-title":"The impact of compression garments on the quality of life in patients with chronic venous disease","volume":"24","author":"Demczyszak I","year":"2017","unstructured":"Demczyszak I, , Sutkowska E, , Jasiak M, et al. The impact of compression garments on the quality of life in patients with chronic venous disease. Fizjoterapia, 2017; 24:19\u201322.","journal-title":"Fizjoterapia"},{"key":"e_1_3_7_37_2","first-page":"CD004174","article-title":"Compression therapy for prevention of post-thrombotic syndrome","volume":"9","author":"Appelen D","year":"2017","unstructured":"Appelen D, , van Loo E, , Prins MH, et al. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev, 2017; 9:CD004174.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01338.x"}],"container-title":["Lymphatic Research and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/lrb.2022.0029","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lrb.2022.0029","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lrb.2022.0029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:14:39Z","timestamp":1777666479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/lrb.2022.0029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4,1]]}},"alternative-id":["10.1089\/lrb.2022.0029"],"URL":"https:\/\/doi.org\/10.1089\/lrb.2022.0029","relation":{},"ISSN":["1539-6851","1557-8585"],"issn-type":[{"value":"1539-6851","type":"print"},{"value":"1557-8585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}